老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bio Blast Pharma

11.50
0.0000
成交量：- -
成交额：- -
市值：482.87万
市盈率：-1.44
高：11.50
开：11.50
低：11.50
收：11.50
52周最高：30.00
52周最低：6.19
股本：41.99万
流通股本：25.59万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-7.9626
每股收益(LYR):-14.3528
净资产收益率：--
总资产收益率：--
市净率：3.10
市盈率(LYR):-0.80

数据加载中...

总览公司新闻资讯公告
2021/06/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/31

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/23

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/09/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2019/07/05

SEC问询函

CORRESP [Cover] - Correspondence
2019/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多